|
|
BOOK REVIEW |
|
Year : 2012 | Volume
: 60
| Issue : 2 | Page : 165 |
|
Therapy for Ocular Angiogenesis: Principles and Practice
S Natarajan
Editor, IJO, CMD, Aditya Jyot Eye Hospital Pvt Ltd, Mumbai, Maharashtra, India
Date of Web Publication | 20-Mar-2012 |
Correspondence Address: S Natarajan Editor, IJO, CMD, Aditya Jyot Eye Hospital Pvt Ltd, Mumbai, Maharashtra India
Source of Support: None, Conflict of Interest: None | Check |
How to cite this article: Natarajan S. Therapy for Ocular Angiogenesis: Principles and Practice. Indian J Ophthalmol 2012;60:165 |
Authors: Arup Das, Thomas Friberg
Publisher: Lippincott Williams & Wilkins
Price: $ 184.00
ISBN: 10: 1605476404, ISBN-13: 978-1605476407
Pages: 464
Pub Date: November 1, 2010
The book which can mould itself according to its reader is the one quality that makes the book worth reading. Since the field of medicine and its various subspecialities deal with facts, it is all the more important to present them in a manner which is easily understandable and visually enhancing to the reader.
This book with its simplicity of presenting ideas on angiogenesis and the crisp language helps the readers to enter the world of ocular angiogenesis with much more confidence.
Its utility for the residents and also use by the research fraternity goes beyond mention. The diagrams which are adapted from the electron microscopy are visually stimulating for the readers in better understanding the process of angiogenesis.
The various trials going in the present era are well described in a concise manner for the readers, who can understand the latest advances in the area of research in the field of angiogenesis.
The key points are summarized at the end of each chapter, which help us to recall the entire work presented in a small paragraph.
Overall it is a beautifully written and well-illustrated book to understand the angiogenesis, which keeps the interest of the reader till the very end. The book is a wonderful combination of the theoretical aspects of angiogenesis and the management of this condition along with the most recent trials which are going on.
|